Autopsy report · NCT01784900
Treatment of Gastric Peritoneal Carcinomatosis by Association of Complete Surgical Resection of the Lesions and Intraperitoneal Immunotherapy Using Catumaxomab
Cause of deathNo reason given
Life of this trial
- Registered 3 months after it had already started.
- Ran for about 3 years 2 months before it stopped.
- 26 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Sponsor type
- University, hospital or other
- Conditions
- Patients With Gastric Peritoneal Carcinomatosis
- Interventions
- Catumaxomab 100µg; Catumaxomab 140µg
- Participants
- 26
- Sites
- 1
- Countries
- France
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.